Fardis Maria has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 13000 shares of CRISPR Therapeutics AG ($CRSP) on June 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | CRISPR Therapeutics AG | $CRSP | Fardis Maria | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 85,774,474 | 9999.99% | 0.02% |
| May 30, 2024 | CRISPR Therapeutics AG | $CRSP | Fardis Maria | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | CRISPR Therapeutics AG | $CRSP | Fardis Maria | Director | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |